卖什么
Accelerating clinical trials and reducing delays
商业模式拆解
买家：谁掌握预算？
未核实Clinical operations/development leads at sponsors; proposal and bid teams at CROs.
触发点：什么让他们现在购买？
Wanting to run a trial with a leaner team and reach first participant faster (sponsors); needing to price bids on precedent and defend change orders (CROs).
工作流：什么输入变成什么输出？
Turn a trial brief into a versioned "living blueprint": feasibility and strategy, design and Schedule of Assessments, risk register, budget or priced bid, protocol and country packs, compliance review; budget moves automatically when design changes.
渠道：怎么接触到客户？
Demo-led ("Book a demo"); separate sponsor and CRO pages; ISO 27001 certified, deployed in the customer region.
融资历史与报道
| 融资日期 | 轮次 | 金额 | 投资方 | 来源 |
|---|---|---|---|---|
| 2026-10-07 | — | €3.8M | — | news.google.com |
档案汇总自公开报道和公司官网。商业模式部分是 MaxBC 对这些材料的解读，不是已确认的事实；未知之处留空，不作猜测。 更新于 2026-10-12.